A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.

Boostrix (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine) - GSK

Boostagen (tetanus toxoid, reduced diphtheria toxoid and recombinant acellular pertussis vaccine, recombinant TdaP) - BioNet Asia

http://www.ncbi.nlm.nih.gov/pubmed/34789403

Nov 21, 2021